NEUROPACE INC. - COMMON STOCK

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference

21 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

06 Nov 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces RNS System Enhancements Designed to Streamline Care

17 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

16 Oct 2023 17:01:49 By Nasdaq GlobeNewswire

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference

20 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Participate in Upcoming Investor Conferences

24 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

08 Aug 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market

19 Jul 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023

18 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces CEO Transition

28 Jun 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales

24 May 2023 16:05:19 By Nasdaq GlobeNewswire

NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

04 May 2023 16:05:01 By Nasdaq GlobeNewswire

NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023

17 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference

03 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results

02 Mar 2023 16:05:01 By Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

10 Feb 2023 08:00:00 By Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors

09 Jan 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

21 Dec 2022 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update

08 Nov 2022 16:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

04 Nov 2022 16:03:00 By Nasdaq GlobeNewswire